Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.63
+0.07440.12%
Post-market: 63.50-0.1290-0.20%16:10 EDT
Volume:9K
Turnover:589.16K
Market Cap:281.24M
PE:20.81
High:63.63
Open:63.27
Low:62.99
Close:63.55
52wk High:64.10
52wk Low:39.10
Shares:4.42M
Float Shares:4.42M
Volume Ratio:0.27
T/O Rate:0.21%
Dividend:1.53
Dividend Rate:2.40%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Space and Defense Co Karman Climbs on S&P Smallcap Addition

Reuters
·
Jul 15

Axsome Says FDA Accepts Axs-12 Narcolepsy Cataplexy NDA, Sets May 1, 2027 PDUFA Date

Reuters
·
Jul 15

Axsome Therapeutics - FDA Sets Pdufa Target Action Date of May 1, 2027 for Axs-12 Nda

THOMSON REUTERS
·
Jul 15

Axsome Therapeutics - FDA Does not Plan Advisory Committee Meeting for Axs-12 Nda

THOMSON REUTERS
·
Jul 15

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for Axs-12 for the Treatment of Cataplexy in Narcolepsy

THOMSON REUTERS
·
Jul 15

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

TIPRANKS
·
Jul 15

BrightSpring Health Services Set to Join S&P MidCap 400 Index

MT Newswires Live
·
Jul 15

BrightSpring Health to replace Chart Industries in S&P 400 at open on 7/17

TIPRANKS
·
Jul 15

S&P Dow Jones Indices: Brightspring Health Services to Replace Chart Industries in S&P Midcap 400

THOMSON REUTERS
·
Jul 15

S&P Dow Jones Indices: Karman Holdings to Replace Brightspring Health Services in S&P Smallcap 600

THOMSON REUTERS
·
Jul 15

Is Axsome Therapeutics (AXSM) Reframing Its CNS Strategy With Pediatric Solriamfetol Trial Expansion?

Simply Wall St.
·
Jul 14

Brightspring Health Svcs is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 14

Guardant Health is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Axsome Therapeutics (AXSM) and Nurix Therapeutics (NRIX)

TIPRANKS
·
Jul 14

Axsome Therapeutics to Report Q2 Financial Results, Host Conference Call

Reuters
·
Jul 14

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

GlobeNewswire
·
Jul 14

Guardant Health price target raised to $205 from $135 at Canaccord

TIPRANKS
·
Jul 14

BrightSpring Health price target raised to $80 from $60 at KeyBanc

TIPRANKS
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and BrightSpring Health Services, Inc. (BTSG)

TIPRANKS
·
Jul 14

Brightspring Health Services Inc : Keybanc Raises Target Price to $80 from $60

THOMSON REUTERS
·
Jul 14